Introduction The biopharma industry is at a crossroads. While large pharmaceutical giants invest billions in digital innovation, mid-market biopharma companies risk falling behind if they don’t embrace digital transformation. Emerging technologies—AI, cloud computing, IoT, and advanced analytics—are reshaping drug discovery, manufacturing, and commercialization. For mid-sized biopharma firms, delaying digital adoption is no longer an option—it’s a competitive necessity. […]
